The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Indolamine 2,3‐dioxygenase is expressed in the CNS and down‐regulates autoimmune inflammation
Abstract
The tryptophan (trp)‐catabolizing enzyme indolamine 2,3‐dioxygenase (IDO) is induced by the T helper 1 (Th 1) cytokine IFN‐γ during infections in various tissues including the brain. Recent studies demonstrated an immune modulatory function of this enzyme, since IDO‐mediated depletion of trp hinders T cell proliferation, while its inhibition by 1‐methyl‐tryptophan (1‐Mt) induces breakdown of immune tolerance in the placenta, leading to rejection of allogeneic concepti. Here, we tested IDO expression and function during experimental autoimmune encephalomyelitis (EAE) actively induced in adult SJL mice by immunization with PLP 139–151 . IDO activity (determined by HPLC analysis of the kynurenine/tryptophan ratio) was increased in the spleen during the preclinical phase, and within the brain and spinal cord at the onset of symptoms. Immunocytochemistry revealed macrophages/activated microglia expressing IDO during EAE and in vitro experiments confirmed IDO induction in microglia upon IFN‐γ treatment with synergistic effects of TNF‐α. Inhibition of IDO by systemic administration of 1‐Mt at clinical onset significantly exacerbated disease scores. From these data, it is tempting to speculate that IFN‐γ from encephalitogenic Th 1 cells induces local IDO expression, thereby initiating a negative feedback loop which may underlie the self‐limitation of autoimmune inflammation during EAE and multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,585
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain
Schwarcz, R., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,263
A role for CD95 ligand in preventing graft rejection
Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A., & Duke, R. C. (1995) · Nature · doi:10.1038/377630a0 · Cited by 1,155
T cell apoptosis by tryptophan catabolism
Fallarino, F., Grohmann, U., Vacca, C., Bianchi, R., Orabona, C., Spreca, A., Fioretti, M. C., & Puccetti, P. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401073 · Cited by 1,022
Pfefferkorn, E. R. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.3.908 · Cited by 854
Priller, J., Flügel, A., Wehner, T., Boentert, M., Haas, C. A., Prinz, M., Fernández-Klett, F., Prass, K., Bechmann, I., de Boer, B. A., et al. (2001) · Nature Medicine · doi:10.1038/nm1201-1356 · Cited by 637
Self-citationWillenborg, D. O., Fordham, S., Bernard, C. C., Cowden, W. B., & Ramshaw, I. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3223 · Cited by 635
Guillemin, G. J., Smythe, G., Takikawa, O., & Brew, B. J. (2005) · Glia · doi:10.1002/glia.20090 · Cited by 497 · cited 1×
“This observation is in line with a recent paper, where human astrocytes and neurons were found to express IDO upon IFN-γ stimulation, yet at a much lower level than microglia (25).”
ResultInterferon‐γ confers resistance to experimental allergic encephalomyelitis
Krakowski, M., & Owens, T. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260735 · Cited by 471
Kamradt, T., & Mitchison, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103013440907 · Cited by 457
Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division
Lee, G. K., Park, H. J., Macleod, M., Chandler, P., Munn, D. H., & Mellor, A. L. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01526.x · Cited by 432
Simultaneous Measurement of Serum Tryptophan and Kynurenine by HPLC,
Widner, B., Werner, E. R., Schennach, H., Wachter, H., & Fuchs, D. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.12.2424 · Cited by 411
Inhibition of experimental asthma by indoleamine 2,3-dioxygenase
Hayashi, T., Beck, L., Rossetto, C., Gong, X., Takikawa, O., Takabayashi, K., Broide, D. H., Carson, D. A., & Raz, E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421275 · Cited by 344
Kassiotis, G., & Kollias, G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.4.427 · Cited by 332
Aktas, O., Waiczies, S., Smorodchenko, A., Dörr, J., Seeger, B., Prozorovski, T., Sallach, S., Endres, M., Brocke, S., Nitsch, R., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021425 · Cited by 282
Self-citationBrocke, S., Gaur, A., Piercy, C., Gautam, A., Gijbels, K., Fathman, C. G., & Steinman, L. (1993) · Nature · doi:10.1038/365642a0 · Cited by 252
Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis
Sakurai, K., Zou, J.-P., Tschetter, J. R., Ward, J. M., & Shearer, G. M. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00176-5 · Cited by 227
Bechmann, I., Mor, G., Nilsen, J., Eliza, M., Nitsch, R., & Naftolin, F. (1999) · Glia · doi:10.1002/(sici)1098-1136(199907)27:1<62::aid-glia7>3.0.co;2-s · Cited by 225
Self-citationImmune surveillance of mouse brain perivascular spaces by blood‐borne macrophages
Bechmann, I., Priller, J., Kovac, A., Böntert, M., Wehner, T., Klett, F. F., Bohsung, J., Stuschke, M., Dirnagl, U., & Nitsch, R. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01793.x · Cited by 214
Self-citationImmune privilege as the result of local tissue barriers and immunosuppressive microenvironments
Streilein, J. W. (1993) · Current Opinion in Immunology · doi:10.1016/0952-7915(93)90064-y · Cited by 214
More Rapid Method for Simultaneous Measurement of Tryptophan and Kynurenine by HPLC
Laich, A., Neurauter, G., Widner, B., & Fuchs, D. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.3.579 · Cited by 193
Interferon-lnduced Indoleamine 2,3-Dioxygenase Activity in Human Mononuclear Phagocytes
Carlin, J. M., Borden, E. C., Sondel, P. M., & Byrne, G. I. (1989) · Journal of Leukocyte Biology · doi:10.1002/jlb.45.1.29 · Cited by 189
TRAIL (Apo-2L) and TRAIL Receptors in Human Placentas: Implications for Immune Privilege
Phillips, T. A., Ni, J., Pan, G., Ruben, S. M., Wei, Y.-F., Pace, J. L., & Hunt, J. S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.6053 · Cited by 189
Hayes, M. P., Rubinow, D., Lane, C., & Markey, S. P. (1989) · Annals of Neurology · doi:10.1002/ana.410260215 · Cited by 188
Alberati‐Giani, D., Ricciardi‐Castagnoli, P., Köhler, C., & Cesura, A. M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66030996.x · Cited by 187
Choi, C. H., Park, J. Y., Lee, J., Lim, J., Shin, E., Ahn, Y. S., Kim, C. H., Kim, S., Kim, J. D., Choi, I., et al. (1999) · PubMed · Cited by 176
Diem, R., Hobom, M., Maier, K., Weissert, R., Storch, M. K., Meyer, R., & Bähr, M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-06993.2003 · Cited by 161
Mechanisms and Time Course of Neuronal Degeneration in Experimental Autoimmune Encephalomyelitis
Hobom, M., Storch, M. K., Weissert, R., Maier, K., Radhakrishnan, A., Kramer, B., Bähr, M., & Diem, R. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00047.x · Cited by 158
Diestel, A., Aktas, O., Hackel, D., Häke, I., Meier, S., Raine, C. S., Nitsch, R., Zipp, F., & Ullrich, O. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030975 · Cited by 155
Self-citationHeyes, M. P., Saito, K., Lackner, A. A., Wiley, C. A., Achim, C. L., & Markey, S. P. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.881 · Cited by 152
Robinson, C. M., Shirey, K. A., & Carlin, J. M. (2003) · Journal of Interferon & Cytokine Research · doi:10.1089/107999003322277829 · Cited by 152
Choi, C., Park, J. Y., Lee, J., Lim, J., Shin, E., Ahn, Y. S., Kim, C., Kim, S., Kim, J.-D., Choi, I. S., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.1889 · Cited by 150
Bechmann, I., Goldmann, J., Kovac, A. D., Kwidzinski, E., Simbürger, E., Naftolin, F. N., Dirnagl, U., Nitsch, R., & Priller, J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2599fje · Cited by 129
Self-citationDäubener, W., & MacKenzie, C. R. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4709-9_64 · Cited by 121
Dörr, J. R., Bechmann, I., Waiczies, S., Aktaş, O., Walczak, H., Krammer, P. H., Nitsch, R., & Zipp, F. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-04-j0001.2002 · Cited by 116
Self-citationOhmori, K., Hong, Y., FUJIWARA, M. T., & Matsumoto, Y. (1992) · PubMed · Cited by 113
Alberati-Giani, D., Malherbe, P., Ricciardi‐Castagnoli, P., Köhler, C., Denis‐Donini, S., & Cesura, A. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.419 · Cited by 101
Currier, A. R., Ziegler, M., Riley, M., Babcock, T., Telbis, V. P., & Carlin, J. (2000) · Journal of Interferon and Cytokine Research · doi:10.1089/107999000312306 · Cited by 92
Astrocyte-induced T cell elimination is CD95 ligand dependent
Bechmann, I., Steiner, B., Gimsa, U., Mor, G., Wolf, S. A., Beyer, M., Nitsch, R., & Zipp, F. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00311-9 · Cited by 70
Self-citationFrontal cortex indoleamine-2,3-dioxygenase activity is increased in HIV-1-associated dementia
Sardar, A. M., & Reynolds, G. P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11324-p · Cited by 67
Bechmann, I., Lossau, S., Steiner, B., Mor, G., Gimsa, U., & Nitsch, R. (2000) · Glia · doi:10.1002/1098-1136(200010)32:1<25::aid-glia30>3.0.co;2-y · Cited by 64
Self-citationBechmann, I., Peter, S., BEYER, M., Gimsa, U., & Nitsch, R. (2001) · The FASEB Journal · doi:10.1096/fj.00-0563fje · Cited by 62
Self-citationBurudi, E. M. E., Marcondes, M. C. G., Watry, D. D., Zandonatti, M. A., Taffe, M. A., & Fox, H. S. (2002) · Journal of Virology · doi:10.1128/jvi.76.23.12233-12241.2002 · Cited by 46
Self-tolerance in the immune privileged CNS: lessons from the entorhinal cortex lesion model
Kwidzinski, E., Mutlu, L. K., Kovac, A. D., Bunse, J., Goldmann, J., Mahlo, J., Aktaş, O., Zipp, F., Kamradt, T., Nitsch, R., et al. (2003) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-0643-3_2 · Cited by 36
Self-citationNettelnbreker, E., Zeidler, H. K., Bartels, H., Dreses‐Werringloer, U., Däubener, W., Holtmann, H., & Köhler, L. (1998) · Journal of Medical Microbiology · doi:10.1099/00222615-47-2-141 · Cited by 28
Depboylu, C., Reinhart, T. A., Takikawa, O., Imai, Y., Maeda, H., Mitsuya, H., Rausch, D. M., Eiden, L. E., & Weihe, E. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03404.x · Cited by 27
(2002) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/s0940-9602(02)80069-3 · Cited by 13
Serotonergic Mechanisms in Levodopa-Induced “On-Off” and Sleep Disorders in Parkinson's Disease
Sandyk, R. (1988) · International Journal of Neuroscience · doi:10.3109/00207458808986171 · Cited by 10
Cited by
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Platten, M., Nollen, E. A. A., Röhrig, U. F., Fallarino, F., & Opitz, C. A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0016-5 · Cited by 1,586
O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002148 · Cited by 1,278
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
Munn, D. H., & Mellor, A. L. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31178 · Cited by 1,078
Multiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938
Maes, M., Yirmyia, R., Noraberg, J., Brene, S., Hibbeln, J., Perini, G., Kubera, M., Bob, P., Lerer, B., & Maj, M. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-008-9118-1 · Cited by 894
Metadata
- Authors
- Kwidzinski, E., Bunse, J., Aktas, O., Richter, D., Mutlu, L., Zipp, F., Nitsch, R., & Bechmann, I.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2005-06-06
- Volume
- 19
- Issue
- 10
- Pages
- 1347-1349
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2128867995
- Cited by
- 289
- References
- 50
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.